{"id":"https://openalex.org/W4282933812","doi":"https://doi.org/10.1158/1538-7445.am2022-5320","title":"Abstract 5320: BRG399, a small molecule modulator of UBE2K demonstrated dose-dependent anti-cancer efficacy in an in vivo model for gastric cancer","display_name":"Abstract 5320: BRG399, a small molecule modulator of UBE2K demonstrated dose-dependent anti-cancer efficacy in an in vivo model for gastric cancer","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282933812","doi":"https://doi.org/10.1158/1538-7445.am2022-5320"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-5320","doi":"https://doi.org/10.1158/1538-7445.am2022-5320","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-5320","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111629061","display_name":"Shiva Kazerounian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shiva Kazerounian","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013545845","display_name":"Mollie O'Hara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mollie O'Hara","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039399228","display_name":"Arcan G\u00fcven","orcid":"https://orcid.org/0000-0002-3407-3609","observed_orcids":["https://orcid.org/0000-0002-3407-3609"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arcan Guven","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025638880","display_name":"Kashni Grover","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kashni Grover","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076442124","display_name":"Nicole Pellegrino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Pellegrino","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018582488","display_name":"Kayleigh Gray","orcid":"https://orcid.org/0000-0002-4329-4040","observed_orcids":["https://orcid.org/0000-0002-4329-4040"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kayleigh Gray","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005292995","display_name":"Can Bruce","orcid":"https://orcid.org/0000-0002-3101-1250","observed_orcids":["https://orcid.org/0000-0002-3101-1250"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Can Bruce","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054206531","display_name":"Gregory M. Miller","orcid":"https://orcid.org/0009-0005-7397-9277","observed_orcids":["https://orcid.org/0009-0005-7397-9277"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory M. Miller","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034581952","display_name":"Maria-Dorothea Nastke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria-Dorothea Nastke","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008685777","display_name":"Michael A. Kiebish","orcid":"https://orcid.org/0000-0002-5678-0072","observed_orcids":["https://orcid.org/0000-0002-5678-0072"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Kiebish","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074904332","display_name":"Eric M. Grund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric M. Grund","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074830972","display_name":"Rangaprasad Sarangarajan","orcid":"https://orcid.org/0000-0001-9403-9421","observed_orcids":["https://orcid.org/0000-0001-9403-9421"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rangaprasad Sarangarajan","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058081424","display_name":"Niven R. Narain","orcid":"https://orcid.org/0000-0001-6769-1748","observed_orcids":["https://orcid.org/0000-0001-6769-1748"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Niven R. Narain","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109782700","display_name":"St\u00e9phane Gesta","orcid":"https://orcid.org/0009-0005-2165-3814","observed_orcids":["https://orcid.org/0009-0005-2165-3814"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephane Gesta","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090366304","display_name":"Vivek K. Vishnudas","orcid":"https://orcid.org/0009-0003-1453-1507","observed_orcids":["https://orcid.org/0009-0003-1453-1507"]},"institutions":[{"id":"https://openalex.org/I4210123108","display_name":"Berg (United States)","ror":"https://ror.org/02twaqp73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210123108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivek K. Vishnudas","raw_affiliation_strings":["1BERG, Framingham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BERG, Framingham, MA","institution_ids":["https://openalex.org/I4210123108"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210123108"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"5320","last_page":"5320"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ube2k","display_name":"UBE2K","score":0.9890000224113464},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.8270000219345093},{"id":"https://openalex.org/keywords/ubiquitin-conjugating-enzyme","display_name":"E2 ubiquitin-conjugating enzyme","score":0.8600000143051147},{"id":"https://openalex.org/keywords/ubiquitin-proteasome-system","display_name":"ubiquitin-proteasome system","score":0.871999979019165},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.640999972820282},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.9039999842643738},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.9670000076293945},{"id":"https://openalex.org/keywords/phosphohistone-h3","display_name":"phosphohistone H3","score":0.8009999990463257},{"id":"https://openalex.org/keywords/drug-target-identification","display_name":"drug target identification","score":0.5040000081062317},{"id":"https://openalex.org/keywords/artificial-intelligence-in-drug-discovery","display_name":"artificial intelligence in drug discovery","score":0.5509999990463257},{"id":"https://openalex.org/keywords/bayesian-networks","display_name":"Bayesian networks","score":0.5389999747276306},{"id":"https://openalex.org/keywords/dose-dependent-efficacy","display_name":"dose-dependent efficacy","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.8277422189712524},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7570287585258484},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5180652141571045},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.48511970043182373},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48084673285484314},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44376519322395325},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.4269344210624695},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4137709140777588},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3154010772705078},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29291361570358276},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11085876822471619},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-5320","doi":"https://doi.org/10.1158/1538-7445.am2022-5320","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-5320","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282928066","https://openalex.org/W7220943775","https://openalex.org/W2593558331","https://openalex.org/W4285806117","https://openalex.org/W3024861063","https://openalex.org/W7164037887","https://openalex.org/W7128377756","https://openalex.org/W4400767488","https://openalex.org/W4395074140","https://openalex.org/W2312318678"],"abstract_inverted_index":{"Abstract":[0],"Gastric":[1],"cancer":[2,107,482],"is":[3,19,66,321],"difficult":[4],"to":[5,80,112,125,189,199,296,350],"treat":[6],"and":[7,21,64,78,185,260,288,315,358,378,382,414],"exhibits":[8],"poor":[9,115],"survival":[10,15],"with":[11,114,180,279,323,372,385],"current":[12],"therapies":[13],"(five-year":[14],"for":[16,23,129,150,214,335,422,480,490],"all":[17],"stages":[18],"32%":[20],"5%":[22],"metastatic":[24],"gastric":[25,106,151,425,481],"cancer)":[26],"demonstrating":[27],"a":[28,37,122,144,231,237,253,306,419,465],"clear":[29],"unmet":[30],"clinical":[31],"need.":[32],"UBE2K":[33,56,102,127,327,470],"was":[34,348],"identified":[35],"as":[36,59,121,303,418],"drug":[38,420],"target":[39],"from":[40,46,73],"the":[41,69,74,81,90,136,224,243,247,263,280,298,324,337,352,364,373,399,409,487],"BERG":[42,117],"Interrogative":[43],"Biology\u00ae":[44],"Platform,":[45],"an":[47,160,389,476],"Artificial":[48],"Intelligence":[49],"derived":[50],"in":[51,103,131,147,164,173,230,285,317,328,398,475,477],"vitro":[52,154],"pan-cancer":[53],"Bayesian":[54],"network.":[55],"(also":[57],"known":[58],"Huntington":[60],"Interacting":[61],"Protein":[62],"2":[63],"E2-25K)":[65],"one":[67],"of":[68,84,92,101,105,139,156,162,170,203,209,226,242,250,257,283,293,300,309,326,332,340,366,369,376,402,412,424,469,486],"~40":[70],"E2":[71,85],"enzymes":[72,86],"Ubiquitin":[75],"Proteasome":[76],"System":[77],"belongs":[79],"Class":[82],"II":[83],"that":[87,220,363,391],"preferentially":[88],"catalyze":[89],"synthesis":[91],"Lys48-linked":[93],"changes":[94],"on":[95,246,271],"monoubiquitinated":[96],"substrates.":[97],"Recently,":[98],"high":[99],"expression":[100],"tumors":[104,186,229],"patients":[108],"has":[109,118],"been":[110],"shown":[111],"associate":[113],"prognosis.":[116],"developed":[119],"BRG399":[120,140,157,171,210,221,284,294,413],"candidate":[123,421],"molecule":[124,467],"modulate":[126],"activity":[128],"use":[130],"oncology.":[132],"Here,":[133],"we":[134],"evaluated":[135],"anti-cancer":[137,410,473],"effect":[138,239,270,292,344],"using":[141,236],"Hs":[142,165,181,227],"746T,":[143],"human":[145],"xenograft":[146],"vivo":[148,478],"model":[149,241,479],"cancer.":[152,426],"In":[153,404],"evaluation":[155],"potency":[158,172],"revealed":[159,219],"IC50":[161],"44.3nM":[163],"746T":[166,182,228],"cells.":[167],"For":[168],"determination":[169],"vivo,":[174],"nude":[175],"mice":[176],"were":[177,187,193],"inoculated":[178],"subcutaneously":[179],"cell":[183,311,333,341],"line":[184],"allowed":[188],"reach":[190],"120mm3.":[191],"Animals":[192],"then":[194],"randomized":[195],"into":[196],"four":[197],"groups":[198],"receive":[200],"oral":[201],"administration":[202],"vehicle,":[204],"75,":[205],"100,":[206],"or":[207],"150mg/kg":[208],"twice":[211],"per":[212],"day":[213,249],"15":[215],"days.":[216],"The":[217],"result":[218,299],"significantly":[222,381],"decreased":[223],"growth":[225,255],"dose-dependent":[232,281,307,472],"manner.":[233],"Statistical":[234],"analysis":[235,361],"mixed":[238],"linear":[240],"tumor":[244,254,289,318,374,386,400],"volumes":[245],"last":[248],"study":[251],"demonstrated":[252,471],"inhibition":[256],"60.3,":[258],"71.2":[259],"85.3%":[261],"at":[262],"three":[264],"doses,":[265],"respectively,":[266],"without":[267],"any":[268],"significant":[269],"body":[272],"weight.":[273],"These":[274],"results":[275,407],"are":[276,380,394],"well":[277],"correlated":[278],"increase":[282],"both":[286],"plasma":[287,367],"tissues.":[290],"Anti-tumor":[291],"appears":[295],"be":[297],"G2/M":[301],"arrest,":[302],"indicated":[304,362],"by":[305],"elevation":[308],"two":[310,356],"cycle-dependent":[312],"biomarkers,":[313],"CNNB1":[314,377],"pHH3,":[316,379],"tissue.":[319],"This":[320,360],"consistent":[322],"role":[325],"regulating":[329],"several":[330],"components":[331],"cycle":[334],"dictating":[336],"precise":[338],"timing":[339],"division.":[342],"Mixed":[343],"multivariable":[345],"regression":[346],"modeling":[347],"employed":[349],"identify":[351],"relationship":[353],"between":[354],"these":[355,392,406],"biomarkers":[357,393],"response.":[359],"level":[365],"concentration":[368],"BRG399,":[370,464],"together":[371],"levels":[375],"negatively":[383],"associated":[384],"volume,":[387],"allowing":[388],"inference":[390],"indicative":[395],"and/or":[396],"involved":[397],"response":[401],"BRG399.":[403],"summary,":[405],"signify":[408],"efficacy":[411,474],"support":[415],"its":[416],"potential":[417],"treatment":[423],"Citation":[427],"Format:":[428],"Shiva":[429],"Kazerounian,":[430],"Mollie":[431],"O'Hara,":[432],"Arcan":[433],"Guven,":[434],"Kashni":[435],"Grover,":[436],"Nicole":[437],"Pellegrino,":[438],"Kayleigh":[439],"Gray,":[440],"Can":[441],"Bruce,":[442],"Gregory":[443],"M.":[444,452],"Miller,":[445],"Maria-Dorothea":[446],"Nastke,":[447],"Michael":[448],"A.":[449],"Kiebish,":[450],"Eric":[451],"Grund,":[453],"Rangaprasad":[454],"Sarangarajan,":[455],"Niven":[456],"R.":[457],"Narain,":[458],"Stephane":[459],"Gesta,":[460],"Vivek":[461],"K.":[462],"Vishnudas.":[463],"small":[466],"modulator":[468],"[abstract].":[483],"In:":[484],"Proceedings":[485],"American":[488],"Association":[489],"Cancer":[491,502],"Research":[492],"Annual":[493],"Meeting":[494],"2022;":[495],"2022":[496],"Apr":[497],"8-13.":[498],"Philadelphia":[499],"(PA):":[500],"AACR;":[501],"Res":[503],"2022;82(12_Suppl):Abstract":[504],"nr":[505],"5320.":[506]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2022-06-16T00:00:00"}